LONDON —WHO presented updated guidance on hepatitis C, calling for drastic simplification of care pathways to alleviate access gaps in HCV testing and treatment, during a joint WHO-EASL-CDC symposium at the International Liver Congress. “In 2016, when WHO launched its global strategy, there were ambitious plans for elimination, defined as a 90% reduction in incidence and a 65%